Guest View
User: Pass: | become a member
Author Archive for Insider Scoop

Whitney Tilson Says More Confident of Herbalife Short Position Following Ackman Presentation

Courtesy of Benzinga.

Whitney Tilson said in an email Tuesday, that he is more confident in his short position in Herbalife (NYSE: HLF), following Bill Ackman’s presentation. Tilson said he now believes his position has a 76% chance of succeeding vs 63% prior. That’s based on his belief that there is a 95% chance most of the company’s operations are a pyramid scheme, and there is now an 80% chance regulators will intervene.

Herbalife shares rose steadily throughout Ackman’s presentation Tuesday, and end the day up 25% at $77.67

Posted-In: News Movers & Shakers Insider Trades General





Benzinga’s M&A Chatter for Thursday July 10, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday July 10, 2014:

ZF Friedrichshafen Confirms in Talks to Buy TRW Automotive

The Offer:
Shares of TRW Automotive (NYSE: TRW) soared Thursday, on a report from Bloomberg that the company could be acquired for as much as $12 billion by Germany’s ZF Friedrichshafen AG.

TRW later confirmed it had been approached by a potential buyer, followed by Friedrichshafen confirming it was in talks to acquire TRW. Shares of TRW were first halted on a circuit-breaker following the Bloomberg report, eventually hitting a high of $101.98, and then prior to the TRW announcement.

TRW Automotive shares closed off the highs Thursday at $98.91, a gain of more than 8%.

Report PE Firms Have Renewed Interest in Symantec

The Rumor:
Shares of Symantec (NYSE: GME) spiked higher Thursday, on a report from Deal Reporter that the company was in takeover talks with private equity firms, including CVC, Carlyle and Bain. Symantec shareholder Valueact reported a new stake of 7.59 million shares on May 14 and has been seeking changes in the company.

Symantec shares closed Thursday at $22.83, a gain of $0.20.

Crumbs Shares Skyrocket 1200% on Potential Investment

The Investment:
Shares of failed cupcake bakery chain Crumbs (OTC: CRMB) rose 1200% Thursday, hitting a high of $0.55, after closing at just $0.03 on Wednesday, on a report from CNBC that the company was close to securing financing from a group including Marcus Lemonis of CNBC’s “The Profit”. Lemonis plans to move other holdings, including Sweet Pete’s into Crumbs. One of he issues causing problems for Crumbs, was its narrow assortment of product, according to CEO Ed Slezak.

Crumbs announced the closing of its stores on July 7, following its shares being delisted from the Nasdaq on July 1.

Crumbs closed Thursday at $0.40, a gain of $0.37.

Posted-In: News Rumors Management Insider Trades M&A Movers





Benzinga’s M&A Chatter for Wednesday July 9, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday July 9, 2014:

Google Rumored to Have Interest in Deal for Time Warner

The Rumor:
Shares of Time Warner (NYSE: TWX) surged higher Tuesday, following a tweet from Fox Business’ Charlie Gasparino, that he has been hearing chatter of a potential bid from Google (NASDAQ: GOOG). Time Warner shares hit a high of $73.07.

Wall Street Journal reporter Doug MacMillan later tweeted that Time Warner’s CEO said his company was not in talks with Google.

Time Warner shares closed off the highs Wednesday at $72.41, a gain of more than 2%.

Hearing Potential Bid for GameStop

The Rumor:
Shares of GameStop (NYSE: GME) spiked higher Wednesday, on renewed unconfirmed market chatter of a potential bid from an unnamed suitor. Chatter had surfaced on June 22 that GameStop had hired an advisor to help it to review strategic alternatives.

A spokesperson for GameStop was unavailable for comment.

GameStop shares closed Wednesday at $41.79, a gain of $0.15.

AbbVie Forced to Retract Comments Regarding Shire Takeover Attempt

The Withdrawn Comments:
AbbVie (NYSE: ABBV) CEO Richard Gonzalez was forced to withdraw comments he made regarding shareholder support for his company’s bid for Shire (NASDAQ: SHPG). The comments were a violation of UK Takeover Panel rules, as the support was not in writing.

AbbVie confirmed today, it had not received commitments of support in writing.

Shire closed Wednesday at $235.08, a gain of almost 1%, while AbbVie lost more than 1% to close at $55.01.

Shareholders Urge Allergan to Make Acquisitions

The CEO Comments:
Allergan (NYSE: AGN) shareholders are encouraging the company to make a large acquisition in order to fight off a $53 billion hostile takeover bid from Valeant Pharmaceuticals (NYSE: VRX) and investor Bill Ackman of Pershing Square, according to a report from Financial Times. Allergan CEO David Pyott, said his company should act quickly in making an acquisition, based on comments from shareholders.

Allergan’s board rejected Valeant’s latest bid of $53 billion in cash and Valeant shares on June 23.

Allergan closed Wednesday at $165.20, a loss of $0.87, while Valeant lost 1% to close at $120.94.

Posted-In: News Hedge Funds Rumors Movers & Shakers Management Insider Trades Movers General





Arena Pharmaceutical Shares Dive On News CEO Sold 40% Of His Shares

Courtesy of Benzinga.

Related ARNA
Benzinga's Top #PreMarket Losers
Markets Marginally Lower Ahead Of Earnings Season

Arena Pharmaceuticals (NASDAQ: ARNA) shares plunged Monday on news that its chief executive Jack Lief sold nearly 40 percent of his holdings in the company.

Lief sold 223,525 shares on July 1 at $5.85 per share. The transaction was an "automatic sell" apparently triggered by a declining share price.

While unusual, the transaction isn't unique among Arena's insider deals. Dominick Behan sold 200,000 shares at $6.30 per share in October, according to filings.

"Lief dumping 40% of his Arena shares all at once when the stock is hitting new lows isn't exactly confidence inspiring," wrote TheStreet columnist Adam Feuerstein.

Feuerstein said the transaction is the death knell of intermittent rumors that Eisai Co. (OTC: ESALY) will acquire Arena.

After opening sharply lower Monday, Arena traded recently at $5.33, down 8.73 percent.

Posted-In: News Insider Trades Movers





American Apparel, Phillips 66 And Others Insiders Have Been Buying

Courtesy of Benzinga.

Related AAP
Worst Performing Industries For July 22, 2014
American Apparel Signs Support Agreement With Standard General

American Apparel, Consolidated Edison and Phillips 66 are among the companies that have seen insider buying recently. Insiders may sell shares for any number of reasons, but conventional wisdom says that insiders really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it.

Pullbacks and sell-offs provide a perfect opportunity for investors who have faith in a company to snap up shares.

Accelerate Diagnostics

Recently, one director and one beneficial owner have picked up more than 38,000 Accelerate Diagnostics (NASDAQ: AXDX) shares combined for a total price of almost $1 million. Note that the same beneficial owner also bought $5 million worth of shares back in May.

This Arizona-based medical research company has a market cap of a little over $1 billion and a return on equity that is in the red. Short interest is more than 10 percent of the total float. Shares have pulled back more than 12 percent from a recent 52-week high. Over the past six months, the stock has outperformed the S&P 500.

American Apparel

Ousted CEO Dov Charney recently scooped up more than 27.3 million shares of American Apparel (NYSE: AAP) as part of his attempt to get the company back. That was worth more than $19.5 million. Hedge fund Standard General is helping Charney, and also bought about 1.5 million shares since.

The market cap is about $9.8 billion. The return on equity is more than 100 percent, but the operating margin is in the red. The share price has swung wildly since Charney's ouster, and over the past six months, the stock has underperformed the likes of Abercrombie & Fitch and Urban Outfitters.

See also: American Apparel Imperiled By Lender's Repayment Demand

Consolidated Edison

A number of executives, including…
continue reading





Benzinga’s Weekend M&A Chatter

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday June 27 through Sunday June 29, 2014:

Tencent Acquires Approximately 20% Stake in 58.com for $736M

The Deal:
58.com (NYSE: WUBA) and Tencent Holdings (OTC: TCEHY) announced Friday that Tencent has agreed to invest $736 million in exchange for approximately 19.9% equity interest in 58.com. Under the agreement, Tencent is purchasing 36.805M Class A and B ordinary shares at $20 per share, or $40 per ADS. 58.com will use part of the proceeds from this transaction to buyback 27,603 million shares from existing pre-IPO shareholders.

58.com closed Friday at $54.90, a gain of 5%.

Rackspace Shares Fall on Reported Lack of Takeover Interest

The Rumor:
Shares of Rackspace (NYSE: RAX) fell sharply Friday, on a report from Deal Reporter that there has been a lack of interest from potential buyers for the web hosting company, due to cash flow issues. Rackspace has been the subject of frequent takeover chatter, with IBM (NYSE: IBM) being often mentioned as a potential suitor.

Rackspace closed Friday at $33.63, a loss of more than 7%.

Pershing Square Settles Poison Pill Litigation

The Settlement:
Bill Ackman’s Pershing Square Capital Management announced Friday, it has reached a settlement with Allergan (NYSE: AGN), resolving the previously announced poison pill litigation before the Delaware Court of Chancery.

The settlement provides that Pershing Square’s solicitation and receipt of revocable proxies to call a special meeting of shareholders of Allergan will not trigger the poison pill, and paves the way for Pershing Square to begin actively soliciting proxies to call the special meeting.

Allergan has rejected Valent Pharmaceutical’s takeover bids, the current offer being $53 billion in cash and Valeant shares. The rejections have prompted Ackman and Valeant to present the offer directly to Allergan shareholders.

Allergan closed Friday at $173.95, a gain of 2%, while Valeant closed at $128.85, a gain of almost 2%.

Posted-In: News Hedge Funds Rumors Movers & Shakers Management Insider Trades M&A General





Benzinga’s M&A Chatter for Tuesday June 24, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday June 24, 2014:

Endo International to Acquire DAVA Pharma for $575M Cash and Up to $25M in Milestone Payments

The Deal:
Endo International (NASDAQ: ENDP) announced Tuesday that it has agreed to acquire privately-held DAVA Pharmaceuticals for $575 million in cash, plus additional cash consideration of up to $25 million contingent on achieving certain sales milestones. The deal is expected to close in H2 of 2014.

Endo International closed Tuesday at $70.26, a gain of more than 2%.

ARC Group Announces Acquisition of Kecy Corporation For $26M

The Deal:
ARC Group Worldwide (ARCW) announced Tuesday, it has agreed to acquire precision metal stamping company, Kecy Corporation for $26 million in cash. The closing of the Kecy Acquisition is expected to occur on June 25, 2014.

ARC Group closed Tuesday at $17.54, a gain of almost 2%.

IMS Health to Acquire Cegedim’s Information Solutions and CRM Businesses for $520M in Cash

The Deal:
IMS Health (NYSE: IMS) announced Tuesday, its intention to acquire certain Cegedim information solutions and Customer Relationship Management businesses for approximately $520 million in cash. The deal is expected to close in early 2015.

IMS Health closed Tuesday at $23.21, and traded as high as $24.76 after-hours.

Valeant CEO Says Major Allergan Shareholders Support $53B Proposal

The CEO Comments:
Shares of Allergan (NYSE: AGN) spiked higher Tuesday, on comments by Valeant (NYSE: VRX) CEO Pearson, that major Allergan shareholders supported the $53 billion bid by Valeant, and the company would soon have enough support for an Allergan shareholder vote on the hostile takeover attempt. Pearson also said Valeant was pursuing no other large deals, while they are working on completing the Allergan deal.

25% of Valeant shareholders are needed to convene the vote. Activist investor Bill Ackman holds almost a 10% stake in Allergan.

Allergan closed Tuesday at $165.35, a gain of $0.53. Valeant closed at $120.52, a loss of $0.69.

Report Aetna Considers Sale of Coventry Health Care Assets Valued at $1.5B

The Rumor:
Aetna (NYSE: …
continue reading





Benzinga’s M&A Chatter for Wednesday July 23, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday July 23, 2014:

Gas Natural Tells Algonquin the Company is ‘Not for Sale’

The Deal:
Algonquin Power & Utilities (OTC: AQUNF) announced Wednesday, that it sent a letter to the Gas Natural (NYSE: EGAS) Board of Directors, urging shareholders to insist on a sale of the company. Algonquin said, over the past seven months, the company has sent three letters and reached out numerous times, to discuss a potential acquisition of Gas Natural, by subsidiary Liberty Utilities.

Liberty’s most recent offer to Gas Natural was $13.00 per share on May 7, 2014. Gas Natural’s response was that the company is “Not for Sale” and refused to discuss the proposed transaction.

Gas Natural shares closed Wednesday at $12.68, a gain of almost 2%.

Talisman Confirms Approach by Repsol

The Deal:
Shares of Talisman Energy (NYSE: TLM) spiked higher Wednesday, ahead of a press release confirming they have been approached by Spain’s Repsol (OTC: REPYY), “with regards to various transactions.” Bloomberg reported Tuesday that Repsol might explore a bid for the Canadian oil and gas company. Repsol also confirmed Wednesday, that the two companies had discussed potential transactions and that Talisman was among potential buyout targets.

Talisman Energy closed Wednesday at $11.17, a gain of more than 13%.

Yahoo Shares Surge on Forbes Report on Potential Takeover

The Rumor:
Shares of Yahoo (NASDAQ: YHOO) spiked higher Wednesday, on a report from Forbes, that it could be a takeover target for Alibaba (NYSE: BABA) or Softbank (OTC: SFTBY). The article’s author, Eric Jackson, who is long Yahoo, said a large shareholder was preparing a presentation mentioning why such an acquisition would be attractive.

Yahoo shares closed Wednesday at $34.71, a gain of more than 3%.

Ariad Shares Move on Fake Twitter Post

The Rumor:
Shares of Ariad Pharmaceuticals (NASDAQ: ARIA) surged higher Wednesday, apparently on a fake Twitter account, claiming to be a Deutsche Bank trader. The fake tweets mentioned Shire (NASDAQ: SHPG) would be announcing a deal with Ariad on Thursday.

Benzinga’s requests for a comment from Ariad were not immediately answered.

Ariad Pharmaceuticals closed Wednesday at $5.88, a gain of 15%. Ariad rose another 7% after-hours.

Posted-In: News Rumors M&A Movers





Yahoo Up; Forbes Columnist Again Speculates On Possible Sale

Courtesy of Benzinga.

Related YHOO
Benzinga's M&A Chatter for Wednesday July 23, 2014
Benzinga's M&A Chatter for Monday July 21, 2014
Publicis, Omnicom See Mixed Results After Merger Flop (Fox Business)

Yahoo (NASDAQ: YHOO) gained more than three percent Wednesday after a Forbes columnist speculated the company may be acquired by Alibaba or Softbank.

The same writer, Eric Jackson, on Monday said Yahoo could be acquired by Facebook, Apple, Microsoft or Google.

Jackson has a long position in Yahoo.

Either Softbank or Alibaba would realize tax advantages in acquiring Yahoo, and use cash from Yahoo's balance sheet to complete the deal, Jackson said.

Alibaba would likely sell Yahoo's core business.

"I suspect they would be concerned that US politicians would object to a big Chinese company having access to Americans' emails," Jackson said.

Softbank might retain the core business.

"Recall that Nikesh Arora just left Google to become Vice Chairman of SoftBank and help build out their US Internet operations." Jackson wrote. "That's the same Arora who tried to get Google to buy Yahoo."

Yahoo closed at $34.71, up 3.3 percent.

Posted-In: ForbesNews Rumors





Talisman Energy Trades Up After Hours; Repsol Reportedly Mulls Bid

Courtesy of Benzinga.

Related TLM
Benzinga's M&A Chatter for Wednesday July 23, 2014
Benzinga's Volume Movers

Talisman Energy (NYSE: TLM) jumped nearly 12 percent in after-hours action on a report that Spain’s Repsol SA is mulling a bid for the Canada-based energy company.

Citing “people familiar with the matter,” Bloomberg news service said Repsol is working with JPMorgan Chase & Co. to evaluate a possible offer.

Repsol said recently it will it spend up to $10 billion on acquisitions in developed markets like the U.S., Canada or northern Europe.

Repsol is flush with cash, receiving $5 billion earlier this year from the Argentine government as payment for nationalizing Repsol’s 51 percent stake in Argentina’s YPF SA in 1999 and a further $1.3 billion from the sale of its then-remaining 12 percent stake.

In May, Talisman Chief Executive Hal Kvisle told the Toronto Globe & Mail that the company would only consider “an aggressive” bid.

“I can’t tell you whether I’d sell for $58,500 a flowing barrel or not, but I’d say that kind of a number makes some sense in the grand range of things,” he said.

Talisman production in the recent quarter equaled 142,000 barrels of oil equivalent per day.

Talisman traded recently after hours at $10.99, up 11.57 percent.

Posted-In: Hal KvisleNews Rumors After-Hours Center





 

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743"

Thank you for you time!

 
 

Chart School

Bulls Take Notice - Caution Suggested as Credit Markets and Equity Markets Diverge

Courtesy of Doug Short.

Summary
  • Divergence with small cap stocks and junk bonds persists.
  • Credit spreads widening suggests building short-term financial stress.
  • Markets oversold and how risk areas react will be telling.

One of the most widely followed market theories is Dow Theory, which has been around for more than 100 years. The essence of Dow Theory is to focus on confirmations or non-confirmations between the Dow Jones Transportation Average and the Dow Jones Industrial Average for assessing market trends and reversals. If one of the indexes breaks out to a new high while the other does not, we have a non-confirmation and the potential for a market reversal.

Similar to Dow Theory I like to look for confirmation between the stock market and the credit markets. When one market does not confirm the other, caution is ...



more from Chart School

Zero Hedge

America The Divided: Everyone Knows We Have Problems But There Is Very Little Agreement On Solutions

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Submitted by Michael Snyder of The Economic Collapse blog,

A house divided against itself will surely fall.  America is more divided today than it has been in decades, and the deep divisions that are tearing us apart continue to get even worse.  In fact, a newly released Rasmussen Reports national survey discovered that ...



more from Tyler

Phil's Favorites

The Piece Fits; Debunking Revisited

Courtesy of Mish.

It Fits 

Reader Eric comments "It is amazing what internet, twitter, etc. has done for the pursuit of truth.  Here is an individual who shows where the piece fits on the plane."

From @ErzaBraam



The Piece



For a report on the piece, please see Photo of MH17 Wreckage Proves Missile Attack

Contrary to popular belief t...



more from Ilene

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Option Review

Starbucks Options Volume Rises Ahead Of Earnings After The Bell

Volume in Starbucks options is running approximately three times the average daily level for the stock as of 1:15 p.m. ET ahead of the company’s third-quarter earnings report after the close. Shares in the name are up roughly 1.0% just before midday to stand at $79.95. Traders of SBUX options today are more active in calls than puts, with the call/put ratio hovering near 2.0 as of the time of this writing. Much of the volume is in 25Jul’14 expiry options contracts, most notably in the $80 and $83 strike calls which have traded roughly 3,350 and 2,550 times respectively and in excess of existing open interest levels in both strikes. A portion of the volume in the $80 and $83 calls appears to be part of a spread trade.

...

more from Caitlin

Insider Scoop

UPDATE: 3M Q2 Earnings Meet Estimates

Courtesy of Benzinga.

Related MMM Earnings Scheduled For July 24, 2014 Stocks To Watch For July 24, 2014 Nasdaq Seen Rallying on Apple, Facebook Results (Fox Business)

3M Company (NYSE: MMM) reported in-line earnings for the second quarter.

The St. Paul, Minnesota-based company posted a quarterly net profit of $1.27 billion, or $1.91 per share, versus a year-ago profit of $1.2 billio...



http://www.insidercow.com/ more from Insider

Sabrient

Sector Detector: Bulls remain unfazed by borderline Black Swans

Courtesy of Sabrient Systems and Gradient Analytics

Despite a highly eventful week in the news, not much has changed from a stock market perspective. No doubt, investors have grown immune to the daily reports of geopolitical turmoil, including Ukraine vs. Russia for control of the eastern regions, Japan’s dispute with China over territorial waters, Sunni vs. Shiite for control of Iraq, Christians being driven out by Islamists, and other religious conflicts in places like Nigeria and Central African Republic. But last Thursday’s news of the Malaysian airliner tragically getting shot down over Ukraine, coupled with Israel’s ground incursion into Gaza, had the makings of a potential Black Swan event, which in my view is the only thing that could derail the relentless bull march higher in stocks.

Nevertheless, when it became clear that the airline...



more from Sabrient

OpTrader

Swing trading portfolio - week of July 21st, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

Here's the latest Stock World Weekly. Please use your PSW user name and password to log in. (You may take a free trial here.)

#452331232 / gettyimages.com ...

more from SWW

Market Shadows

Danger: Falling Prices

Danger: Falling Prices

By Dr. Paul Price of Market Shadows

 

We tried holding up stock prices but couldn’t get the job done. Market Shadows’ Virtual Value Portfolio dipped by 2% during the week but still holds on to a market-beating 8.45% gain YTD. There was no escaping the downdraft after a major Portuguese bank failed. Of all the triggers for a large selloff, I’d guess the Portuguese bank failure was pretty far down most people's list of "things to worry about." 

All three major indices gave up some ground with the Nasdaq composite taking the hardest hi...



more from Paul

Digital Currencies

Bitcoin Vs Gold - The Infographic

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

While Marc Faber has said "I will never sell my gold," he also noted "I like the idea of Bitcoin," and the battle between the 'alternative currencies' continues. The following infographic provides a succinct illustration of the similarities and differences between gold and bitcoin.

Please include attribution to www.jmbullion.com with this graphic.

...

more from Bitcoin

Pharmboy

Biotechs & Bubbles

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well PSW Subscribers....I am still here, barely.  From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.

First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices.  Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment.  Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer.  For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...



more from Pharmboy

Promotions

See Live Demo Of This Google-Like Trade Algorithm

I just wanted to be sure you saw this.  There’s a ‘live’ training webinar this Thursday, March 27th at Noon or 9:00 pm ET.

If GOOGLE, the NSA, and Steve Jobs all got together in a room with the task of building a tremendously accurate trading algorithm… it wouldn’t just be any ordinary system… it’d be the greatest trading algorithm in the world.

Well, I hate to break it to you though… they never got around to building it, but my friends at Market Tamer did.

Follow this link to register for their training webinar where they’ll demonstrate the tested and proven Algorithm powered by the same technological principles that have made GOOGLE the #1 search engine on the planet!

And get this…had you done nothing b...



more from Promotions



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>